The Strand team is excited to announce our participation in the Association for Molecular Pathology (AMP) 2023 Annual Meeting in Salt Lake City, Utah this November! 

As we gear up for the event, some highlights we are particularly looking forward to include: 

1. Our poster presentation: Dr. Urvashi Bahadur, our VP of Clinical Diagnostics will present our latest findings on the Strand Homologous Recombination Deficiency (HRD) test and its role in detecting genomic instability. Additionally, this is a great opportunity to learn how determining HRD status can impact the suitability of PARP inhibitor therapy. 

Learn more about ‘Clinical Utility of Homologous Recombination Deficiency (HRD) Profiling in Ovarian Cancer - An Indian Experience’ on November 18th from 9:15 am – 10:15 am MT at the Expo Hall, poster# ST051

2. AMP scientific sessions: The impressive speaker lineup this year has us wearing our inquisitive trainee hats. We are especially eager to learn more about the advancements in clinical grade knowledgebases and spatial genomics in solid tumors.

3. Socials & networking: We are thrilled to be engaging with fellow scientists and industry professionals, gaining insights into the latest advancements in cancer genomics.

If you will be at AMP23, be sure to visit our poster or chat with us during the socials or both!